Found: 18
Select item for more details and to access through your institution.
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 7, p. 752, doi. 10.3390/jpm14070752
- By:
- Publication type:
- Article
Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 5, p. 657, doi. 10.1007/s40257-018-0359-4
- By:
- Publication type:
- Article
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1357, doi. 10.3390/vaccines11081357
- By:
- Publication type:
- Article
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11926-2
- By:
- Publication type:
- Article
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2611, doi. 10.3390/cancers16142611
- By:
- Publication type:
- Article
Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5384, doi. 10.3390/cancers15225384
- By:
- Publication type:
- Article
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5052, doi. 10.3390/cancers15205052
- By:
- Publication type:
- Article
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4808, doi. 10.3390/cancers15194808
- By:
- Publication type:
- Article
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3754, doi. 10.3390/cancers15153754
- By:
- Publication type:
- Article
Frequent Prosthesis Refitting to Prevent Implant Exposure in Patients With Retinoblastoma.
- Published in:
- Journal of Pediatric Ophthalmology & Strabismus, 2011, v. 48, n. 4, p. 238, doi. 10.3928/01913913-20100818-06
- By:
- Publication type:
- Article
Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2618, doi. 10.1007/s12094-024-03484-7
- By:
- Publication type:
- Article
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 4, p. 496, doi. 10.1007/s11864-024-01189-1
- By:
- Publication type:
- Article
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac012
- By:
- Publication type:
- Article
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 7, p. 610, doi. 10.3390/biology10070610
- By:
- Publication type:
- Article
Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.
- Published in:
- Clinical Ophthalmology, 2014, v. 8, p. 1377, doi. 10.2147/OPTH.S64138
- By:
- Publication type:
- Article
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.
- Published in:
- Clinical Ophthalmology, 2010, v. 4, p. 519
- By:
- Publication type:
- Article
Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 47, doi. 10.2147/CMAR.S73389
- By:
- Publication type:
- Article
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8<sup>+</sup> T cell cytolytic killing of melanoma cells.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01352-x
- By:
- Publication type:
- Article